首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1792259

神經刺激設備市場報告（按刺激類型、設備類型、應用、最終用戶和地區）2025 年至 2033 年

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2025-2033

出版日期: 2025年08月01日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年，全球神經刺激設備市場規模達96億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到220億美元，2025-2033年期間的複合年成長率（CAGR）為9.21%。人口老化加劇、醫療支出不斷成長、非侵入性或微創神經刺激技術的發展，以及政府和私人醫療保險公司報銷政策的改進，是推動市場發展的主要因素。

神經刺激裝置是一種先進的醫療技術，旨在調節和影響人體內的神經活動。這些裝置透過向神經系統的特定區域傳遞電脈衝或磁脈衝來發揮作用，旨在緩解各種神經系統疾病和慢性疾病。它們提供了一種前景光明的非侵入性或微創治療方法，能夠提高患者的生活品質，並可能為治療各種神經系統疾病開闢新的途徑。神經刺激裝置主要分為兩種：深部腦部刺激 (DBS) 和脊髓刺激 (SBS)。 DBS 是指將電極植入目標腦區，以調節異常神經訊號，並治療帕金森氏症、特發性震顫和肌張力失調等疾病。

日益成長的老齡化人口正在推動全球市場的發展。隨著老齡人口的成長，用於治療這些疾病的神經刺激設備的需求可能會上升。此外，非侵入性或微創神經刺激技術的發展擴大了潛在的患者群體，因為與傳統外科手術相比，這些治療方案通常風險更低、恢復時間更短。此外，一些地區的政府和私人醫療保險機構改進了報銷政策，使患者更容易獲得神經刺激治療，從而促進了市場的成長。此外，正在進行的研究和臨床試驗也為神經刺激設備的安全性和有效性提供了更多證據。這些研究的積極成果增強了醫務人員和患者對該技術的信心。此外，醫療保健支出的不斷成長也支持了市場解決方案的成長，因為神經刺激設備提供了一種經濟高效的慢性病管理方法，這推動了其應用。

神經刺激設備市場趨勢/促進因素：

神經系統疾病盛行率不斷上升

帕金森氏症、癲癇、慢性疼痛和憂鬱症等神經系統疾病困擾著全球數百萬人，造成了沉重的醫療負擔。神經刺激裝置為那些對常規療法無效或副作用嚴重的患者提供了一個相當有前景的解決方案。深部腦部刺激 (DBS) 在治療帕金森氏症等運動障礙方面已顯示出顯著療效，從而增加了對這些裝置的需求。此外，慢性疼痛的發生率不斷上升，尤其是由於人口老化和久坐不動的生活方式，這推動了對脊髓刺激 (SCS) 裝置的需求，以便在不過度依賴藥物的情況下緩解疼痛。隨著政府和醫療機構將改善患者治療效果放在首位並尋求創新解決方案，神經刺激裝置的需求預計將穩定成長。

神經刺激技術的持續進步

持續的研發投入催生了更精密、更精準的神經刺激設備。創新包括更小巧、更精準的電極、更長的電池壽命，以及能夠根據患者即時需求自動調整刺激參數的閉迴路系統整合。這些進步轉化為更佳的治療效果、更少的副作用和更高的患者舒適度。此外，神經刺激設備微創植入技術的發展，使其適用範圍擴大到更廣泛的患者群體，使治療更容易獲得，也更受患者和醫護人員的青睞。隨著技術的不斷發展，神經刺激設備有望變得更有效率和適應性強，從而進一步推動其普及和市場滲透。

神經調節療法的認知度和接受度不斷提高

隨著越來越多的臨床證據支持神經刺激設備在治療各種神經系統疾病的有效性，醫生擴大向患者推薦這些療法。此外，患者權益組織和宣傳活動在向大眾普及神經刺激的潛在益處方面發揮了至關重要的作用，從而提高了患者對這些療法的接受度。患者透過神經刺激設備顯著改善生活品質的成功案例，進一步增強了人們對這些療法的正面看法。隨著人們對神經調節的信任度不斷提升，預計對這些設備的需求將會增加，從而推動市場擴張。此外，醫療保健機構、研究人員和設備製造商之間為提高認知度並確保合理使用而進行的合作，將有助於神經刺激設備市場的持續成長。

The global neurostimulation devices market size reached USD 9.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.

The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.

Neurostimulation Devices Market Trends/Drivers:

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.

Continual Advancements in Neurostimulation Technologies

Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.

Growing Awareness and Acceptance of Neuromodulation Therapies

As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.

Neurostimulation Devices Industry Segmentation:

Breakup by Stimulation Type:

Internal Stimulation
External Stimulation

Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.

On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.

Breakup by Device Type:

SCS (Spinal Cord Stimulation) Devices
DBS (Deep Brain Stimulation) Devices
SNS (Sacral Nerve Stimulation) Devices
VNS (Vagus Nerve Stimulation) Devices
GES (Gastric Electrical Stimulation) Devices
Transcutaneous Electrical Nerve Stimulation Devices
Transcranial Magnetic Stimulation Devices
Others

SCS (spinal cord stimulation) dominates the market

SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.

Breakup by Application:

Pain Management
Epilepsy
Essential Tremors
Urinary and Fecal Incontinence
Depression
Dystonia
Parkinson's Disease
Others

Pain management dominates the market

Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.

Breakup by End-User:

Rehabilitation Centers
Hospitals
Medical Clinics
Others

Hospitals dominates the market

Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.

Breakup by Region:

North America
- United States
- Canada
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.

Competitive Landscape:

Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Biocontrol Medical
Boston Scientific Corporation
Cyberonics Inc.
Medtronic Inc.
Neuronetics Inc.
Neuropace Inc.
Neurosigma Inc.
Nevro Corporation
ST. Jude Medical Inc.
Synapse Biomedical Inc.

Key Questions Answered in This Report

1.What was the size of the global neurostimulation devices market in 2024?
2.What is the expected growth rate of the global neurostimulation devices market during 2025-2033?
3.What are the key factors driving the global neurostimulation devices market?
4.What has been the impact of COVID-19 on the global neurostimulation devices market?
5.What is the breakup of the global neurostimulation devices market based on the device type?
6.What is the breakup of the global neurostimulation devices market based on the application?
7.What is the breakup of the global neurostimulation devices market based on the end-user?
8.What are the key regions in the global neurostimulation devices market?
9.Who are the key players/companies in the global neurostimulation devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Stimulation Type

6.1 Internal Stimulation
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 External Stimulation
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Device Type

7.1 SCS (Spinal Cord Stimulation) Devices
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 DBS (Deep Brain Stimulation) Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 SNS (Sacral Nerve Stimulation) Devices
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 VNS (Vagus Nerve Stimulation) Devices
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 GES (Gastric Electrical Stimulation) Devices
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Transcutaneous Electrical Nerve Stimulation Devices
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Transcranial Magnetic Stimulation Devices
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
7.8 Others
- 7.8.1 Market Trends
- 7.8.2 Market Forecast

8 Market Breakup by Application

8.1 Pain Management
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Epilepsy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Essential Tremors
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Urinary and Fecal Incontinence
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Depression
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Dystonia
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Parkinson's Disease
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast

9 Market Breakup by End-User

9.1 Rehabilitation Centers
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Hospitals
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Medical Clinics
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Europe
- 10.2.1 Germany
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 France
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 United Kingdom
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 Italy
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Spain
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Russia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Asia Pacific
- 10.3.1 China
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 Japan
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 India
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 South Korea
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Australia
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Indonesia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

12.1 Overview
12.2 Inbound Logistics
12.3 Operations
12.4 Outbound Logistics
12.5 Marketing and Sales
12.6 Post Sales Services

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Biocontrol Medical
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Boston Scientific Corporation
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Cyberonics Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Medtronic Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Neuronetics Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
- 15.3.6 Neuropace Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Neurosigma Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Nevro Corporation
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
- 15.3.9 ST. Jude Medical Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Synapse Biomedical Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2024
Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2024
Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2024
Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2024
Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2024
Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2024
Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million USD), 2025-2033
Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Neurostimulation Devices Market: Competitive Structure
Table 8: Global: Neurostimulation Devices Market: Key Players

02-2729-4219

+886-2-2729-4219